FDA
- Application: ANDA217509
- Marketing authorisation holder: TEVA PHARMACEUTICALS USA, INC.
- Local brand name: BINIMETINIB
- Indication: TABLET
- Status: approved
Mektovi (binimetinib) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
TEVA PHARMACEUTICALS USA, INC. holds the US marketing authorisation.